Memento Medicines raised $93 million in Series A funding. The round supports the company's development of precision medicines for neurodegenerative diseases. The financing represents one of the larger early-stage rounds in the biotech sector this year.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
Cellares Raises $327M in Series D Funding